{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:46:46Z","timestamp":1790322406605,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>We present a case report of a child with features of hyperphosphatasia with neurologic deficit (HPMRS) or Mabry syndrome (MIM 239300) with variants of unknown significance in two post-GPI attachments to proteins genes, PGAP2 and PGAP3, that underlie HPMRS 3 and 4. Background: In addition to HPMRS 3 and 4, disruption of four phosphatidylinositol glycan (PIG) biosynthesis genes, PIGV, PIGO, PIGW and PIGY, result in HPMRS 1, 2, 5 and 6, respectively. Methods: Targeted exome panel sequencing identified homozygous variants of unknown significance (VUS) in PGAP2 c:284A&gt;G and PGAP3 c:259G&gt;A. To assay the pathogenicity of these variants, we conducted a rescue assay in PGAP2 and PGAP3 deficient CHO cell lines. Results: Using a strong (pME) promoter, the PGAP2 variant did not rescue activity in CHO cells and the protein was not detected. Flow cytometric analysis showed that CD59 and CD55 expression on the PGAP2 deficient cell line was not restored by variant PGAP2. By contrast, activity of the PGAP3 variant was similar to wild-type. Conclusions: For this patient with Mabry syndrome, the phenotype is likely to be predominantly HPMRS3: resulting from autosomal recessive inheritance of NM_001256240.2 PGAP2 c:284A&gt;G, p.Tyr95Cys. We discuss strategies for establishing evidence for putative digenic inheritance in GPI deficiency disorders.<\/jats:p>","DOI":"10.3390\/genes14020359","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T07:34:41Z","timestamp":1675064081000},"page":"359","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Excluding Digenic Inheritance of PGAP2 and PGAP3 Variants in Mabry Syndrome (OMIM 239300) Patient: Phenotypic Spectrum Associated with PGAP2 Gene Variants in Hyperphosphatasia with Mental Retardation Syndrome-3 (HPMRS3)"],"prefix":"10.3390","volume":"14","author":[{"given":"Miles D.","family":"Thompson","sequence":"first","affiliation":[{"name":"Adult Genetic Epilepsy (AGE) Program, Toronto Western Hospital, Krembil Brain Institute, Toronto, ON M5T, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Li","sequence":"additional","affiliation":[{"name":"Osaka University, 3-1 Yamada-Oka, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Spencer-Manzon","sequence":"additional","affiliation":[{"name":"Departments of Genetics and Pediatrics, Yale University, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0953-2698","authenticated-orcid":false,"given":"Danielle M.","family":"Andrade","sequence":"additional","affiliation":[{"name":"Adult Genetic Epilepsy (AGE) Program, Toronto Western Hospital, Krembil Brain Institute, Toronto, ON M5T, Canada"},{"name":"Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON M5S, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Murakami","sequence":"additional","affiliation":[{"name":"Osaka University, 3-1 Yamada-Oka, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taroh","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Osaka University, 3-1 Yamada-Oka, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-6768","authenticated-orcid":false,"given":"Thomas O.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Yale Pediatrics (Endocrinology), Yale University School of Medicine, New Haven, CT 06521, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3476(70)80047-6","article-title":"Familial hyperphosphatase with mental retardation, seizures, and neurologic deficits","volume":"77","author":"Mabry","year":"1970","journal-title":"J. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ajmg.a.33438","article-title":"Hyperphosphatasia with seizures, neurologic deficit, and characteristic facial features: Five new patients with Mabry syndrome","volume":"152A","author":"Thompson","year":"2010","journal-title":"Am. J. Med. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-94-017-7197-9_16","article-title":"Neurogenetic aspects of hyperphosphatasia in Mabry syndrome","volume":"76","author":"Cole","year":"2015","journal-title":"Subcell. Biochem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13023-020-1313-0","article-title":"Significantly different clinical phenotypes associated with mutations in synthesis and transamidase + remodeling glycosylphosphatidylinositol (GPI)-anchor biosynthesis genes","volume":"15","author":"Carmody","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.653","article-title":"Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome","volume":"42","author":"Krawitz","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13073-017-0510-5","article-title":"Characterization of glycosylphosphatidylinositol biosynthesis defects by clinical features, flow cytometry, and automated image analysis","volume":"10","author":"Knaus","year":"2018","journal-title":"Genome Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10545-014-9752-1","article-title":"Human genetic disorders involving glycosylphosphatidylinositol (GPI) anchors and glycosphingolipids (GSL)","volume":"38","author":"Ng","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/humu.23016","article-title":"Recessive PIGN Mutations in Fryns Syndrome: Evidence for Genetic Heterogeneity","volume":"37","author":"Thompson","year":"2016","journal-title":"Hum. Mutat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/cge.13425","article-title":"Clinical variability in inherited glycosylphosphatidylinositol deficiency disorders","volume":"95","author":"Nguyen","year":"2019","journal-title":"Clin. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1194\/jlr.R063313","article-title":"Biosynthesis of GPI-anchored proteins: Special emphasis on GPI lipid remodeling","volume":"57","author":"Kinoshita","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ajhg.2019.05.019","article-title":"Mutations in PIGB cause an inherited GPI biosynthesis defect with an axonal neuropathy and metabolic abnormality in severe cases","volume":"105","author":"Murakami","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajhg.2018.08.014","article-title":"Mutations in PIGS, encoding a GPI transamidase, cause a neurological syndrome ranging from fetal akinesia to epileptic encephalopathy","volume":"103","author":"Nguyen","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejmg.2010.01.002","article-title":"Hyperphosphatasia with mental retardation, brachytelephalangy, and a distinct facial gestalt: Delineation of a recognizable syndrome","volume":"53","author":"Horn","year":"2010","journal-title":"Eur. J. Med. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ajmg.a.35202","article-title":"Phenotypic variability in hyperphosphatasia with seizures and neurologic deficit (Mabry syndrome)","volume":"158A","author":"Thompson","year":"2012","journal-title":"Am. J. Med. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pediatrneurol.2005.08.020","article-title":"Hyperphosphatasia with neurologic deficit: A pyridoxine-responsive seizure disorder?","volume":"34","author":"Thompson","year":"2006","journal-title":"Pediatr. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.braindev.2016.04.008","article-title":"Clinical and genetic analysis of two Chinese infants with Mabry syndrome","volume":"38","author":"Xue","year":"2016","journal-title":"Brain Dev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ajhg.2012.05.004","article-title":"Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation","volume":"91","author":"Krawitz","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1111\/epi.12508","article-title":"PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels","volume":"55","author":"Nakamura","year":"2014","journal-title":"Epilepsia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmedgenet-2013-102156","article-title":"Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome","volume":"51","author":"Chiyonobu","year":"2014","journal-title":"J. Med. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1093\/hmg\/ddv331","article-title":"Mutations in PIGY: Expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies","volume":"24","author":"Ilkovski","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ajhg.2013.03.008","article-title":"Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability","volume":"92","author":"Hansen","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2016.10.027","article-title":"A novel mutation in PGAP2 gene causes developmental delay, intellectual disability, epilepsy and microcephaly in consanguineous Saudi family","volume":"371","author":"Naseer","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ajhg.2013.03.011","article-title":"PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome","volume":"92","author":"Krawitz","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejpn.2016.01.007","article-title":"Congenital disorder of glycosylphosphatidylinositol (GPI)-anchor biosynthesis\u2014The phenotype of two patients with novel mutations in the PIGN and PGAP2 genes","volume":"20","author":"Ciara","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ajhg.2013.12.012","article-title":"Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation","volume":"94","author":"Howard","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/humu.23006","article-title":"Rare noncoding mutations extend the mutational spectrum in the PGAP3 subtype of hyperphosphatasia with mental retardation syndrome","volume":"37","author":"Knaus","year":"2016","journal-title":"Hum. Mutat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpeds.2019.07.021","article-title":"50 Years Ago in The Journal of Pediatrics: Familial Hyperphosphatasia with Mental Retardation, Seizures, and Neurologic Deficits","volume":"222","author":"Thompson","year":"2020","journal-title":"J. Pediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103822","DOI":"10.1016\/j.ejmg.2019.103822","article-title":"A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: Molecular genetics of the prototypical inherited GPI disorder","volume":"63","author":"Thompson","year":"2020","journal-title":"Eur. J. Med. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1091\/mbc.e05-11-1005","article-title":"PGAP2 is essential for correct processing and stable expression of GPI-anchored proteins","volume":"17","author":"Tashima","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1091\/mbc.e06-10-0885","article-title":"Fatty acid remodeling of GPI-anchored proteins is required for their raft association","volume":"18","author":"Maeda","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/humu.24461","article-title":"Long read sequencing and expression studies of AHDC1 deletions in Xia-Gibbs syndrome reveal a novel genetic regulatory mechanism","volume":"4","author":"Chander","year":"2022","journal-title":"Hum. Mutat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000518689","article-title":"Intragenic Deletion of the ZMYND11 Gene in 10p15.3 is Associated with Developmental Delay Phenotype: A Case Report","volume":"161","author":"Huynh","year":"2021","journal-title":"Cytogenet. Genome Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"De Luca, O., Salerno, G., De Bernardini, D., Torre, M.S., Simmaco, M., Lionetto, L., Gentile, G., and Borro, M. (2022). Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213923"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1212\/WNL.0000000000004689","article-title":"Pyruvate dehydrogenase complex-E2 deficiency causes paroxysmal exercise-induced dyskinesia","volume":"89","author":"Friedman","year":"2017","journal-title":"Neurology"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/2\/359\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:19:59Z","timestamp":1760120399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/2\/359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["genes14020359"],"URL":"https:\/\/doi.org\/10.3390\/genes14020359","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]}}}